1. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet. 1992;340(8827):1053–8.
2. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Can Res. 1995;55(19):4273–7.
3. Yoshida K, Goodison S, Sugino T, Bolodeoku J, Churchman M, Warren BF, et al. Semiquantitative detection of abnormal CD44 transcripts in colon carcinomas by reverse transcription-polymerase chain reaction enzyme-linked immunosorbant assay (RT-PCR ELISA). Mol Diagn. 1996;1(3):167–73.
4. Woodman AC, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, et al. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol. 1996;149(5):1519–30.
5. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ. 1994;308(6929):619–24.